BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 2
• 3
• 4
• 5
• 6
• 7

• Press Releases

  Quarterly Report Q3 2025: Orviglance NDA Submitted to the FDA

  November 5, 2025

   · 

  3 min read
• Press Releases

  Santhera Closes USD 13 Million Royalty Monetization Agreement

  November 5, 2025

   · 

  2 min read
• Press Releases

  Invitation to the Presentation of Cantargia’s Interim Report January-September 2025

  November 5, 2025

   · 

  2 min read
• Press Releases

  Vicore to Present at Upcoming November 2025 Investor Conferences

  November 5, 2025

   · 

  1 min read
• Press Releases

  Driven by Strong Demand, ImmunityBio Reports 467% Year-to-Date Unit Growth and $75 Million in Sales Year-to-Date, Up 434% from Q3 2024

  November 5, 2025

   · 

  18 min read
• Press Releases

  Innate Pharma Announces Conference Call and Webcast for Third Quarter 2025 Results and Business Updates

  November 5, 2025

   · 

  4 min read
• Press Releases

  Evotec SE Reports 9M 2025 Results: Continued Strong Execution on Strategic Priorities

  November 5, 2025

   · 

  7 min read
• Press Releases

  Novo Nordisk’s sales increased by 12% in Danish kroner and by 15% at CER in the first nine months of 2025; R&D pipeline progress continues

  November 5, 2025

   · 

  4 min read
• Press Releases

  U.S. FDA Grants Orphan Drug Designation to Leukogene Therapeutics’ M2T-CD33 (LTI-214) for the Treatment of Acute Myeloid Leukemia

  November 5, 2025

   · 

  2 min read
• Press Releases

  Palvella Therapeutics Announces New QTORIN™ Product Candidate, QTORIN™ Pitavastatin, for the Treatment of Disseminated Superficial Actinic Porokeratosis (DSAP), a Rare, Chronic, and Pre-Cancerous Genetic Skin Disease with No FDA-Approved Therapies

  November 5, 2025

   · 

  7 min read